Lazard Asset Management
SGYP

Lazard Asset Management’s Synergy Pharmaceuticals, Inc Common Stock SGYP Stock Holding History

Lazard Asset Management’s Portfolio SGYP Stock Details SGYP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q3 		– Sell
-49,076
Closed -$407K – 1194
2015
Q2 		$407K Buy
+49,076
New +$238K ﹤0.01% 766

Other funds holding SGYP

PC
Paulson & Co New York $3.11B AUM 94.93% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Lazard Asset Management's SGYP Position: Q3 2015 in Review

Lazard Asset Management sold out of Synergy Pharmaceuticals, Inc Common Stock (SGYP) in Q3 2015, closing a stake of 49,076 shares — an estimated $407K sold.

Lazard Asset Management first reported a position in SGYP in Q2 2015 and held it in 1 quarter. The position peaked at $407K in Q2 2015. 129 funds tracked by Wall St. Rank hold SGYP as of Q3 2015.

  • Lazard Asset Management reported no remaining Synergy Pharmaceuticals, Inc Common Stock position as of Q3 2015 after selling out during the quarter.
  • Lazard Asset Management sold 49,076 Synergy Pharmaceuticals, Inc Common Stock shares in Q3 2015, an estimated $407K.
  • Lazard Asset Management first reported a position in Synergy Pharmaceuticals, Inc Common Stock in Q2 2015 and held it in 1 quarter.
  • Lazard Asset Management's Synergy Pharmaceuticals, Inc Common Stock position peaked at $407K in Q2 2015.
  • 129 funds tracked by Wall St. Rank held Synergy Pharmaceuticals, Inc Common Stock as of Q3 2015.

Based on Lazard Asset Management's 13F filing for Q3 2015, filed 13 Nov 2015.